Vladimir N Chubarev (Vladimir Chubarev)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 11

Top Topics

Saccharomyces Cerevisiae

Mesenchymal Stem Cells

Top Venues

International journal of molecular sciences

Current medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Sabina Abdullaeva, Vladimir N Chubarev, Anna Valeeva, Nina Preferanskaya, Margarita E Neganova, Elena A Smolyarchuk, Junqi Liu, Olga A Sukocheva, Mikhail Samsonov, Renad N Alyautdin
Analysis of Clinical Success and Molecular Mechanisms of Action of Novel Anti-glioblastoma Drugs: A Review. Current medicinal chemistry (2024)
Eugenia D Namiot, Aleksandr V Sokolov, Vladimir N Chubarev, Vadim V Tarasov, Helgi B Schiöth
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines. International journal of molecular sciences 24 (1) (2023)
Eugenia D Namiot, Aleksandr V Sokolov, Vladimir N Chubarev, Vadim V Tarasov, Helgi B Schiöth
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines. International journal of molecular sciences 24 (1) (2023)
Eugenia D Namiot, Aleksandr V Sokolov, Vladimir N Chubarev, Vadim V Tarasov, Helgi B Schiöth
Nanoparticles in Clinical Trials: Analysis of Clinical Trials, FDA Approvals and Use for COVID-19 Vaccines. International journal of molecular sciences 24 (1) (2023)
Farzin Zobdeh, Ivan I Eremenko, Mikail A Akan, Vadim V Tarasov, Vladimir N Chubarev, Helgi B Schiöth, Jessica Mwinyi
The Epigenetics of Migraine. International journal of molecular sciences 24 (11) (2023)
Eugenia D Namiot, Jenni Viivi Linnea Niemi, Vladimir N Chubarev, Vadim V Tarasov, Helgi B Schiöth
Stem Cells in Clinical Trials on Neurological Disorders: Trends in Stem Cells Origins, Indications, and Status of the Clinical Trials. International journal of molecular sciences 23 (19) (2022)
Alina A Bagdasaryan, Vladimir N Chubarev, Elena A Smolyarchuk, Vladimir N Drozdov, Ivan I Krasnyuk, Junqi Liu, Ruitai Fan, Edmund Tse, Evgenia V Shikh, Olga A Sukocheva
Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. Cancers 14 (21) (2022)
Farzin Zobdeh, Ivan I Eremenko, Mikail A Akan, Vadim V Tarasov, Vladimir N Chubarev, Helgi B Schiöth, Jessica Mwinyi
Pharmacogenetics and Pain Treatment with a Focus on Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) and Antidepressants: A Systematic Review. Pharmaceutics 14 (6) (2022)
Daria Petrenko, Vladimir N Chubarev, Nikita Syzrantsev, Nafeeza Mohd Ismail, Vadim Merkulov, Susanna S Sologova, Ekaterina Grigorevskikh, Elena Smolyarchuk, Renad N Alyautdin
Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems. Molecules (Basel, Switzerland) 27 (11) (2022)
Vladimir N Chubarev, Narasimha M Beeraka, Mikhail Yegorovich Sinelnikov, Kirill V Bulygin, Vladimir N Nikolenko, Elizaveta V Mikhaylenko, Vadim V Tarasov, Liudmila M Mikhaleva, Palmiro Poltronieri, Vijaya Padma Viswanadha, Siva G Somasundaram, Cecil E Kirkland, Kuo Chen, Junqi Liu, Ruitai Fan, Mohammad Amjad Kamal, Alexander A Mironov, SubbaRao V Madhunapantula, Douglas B Kell, Sergey V Dindyaev, Cristian Muresanu, Olga A Sukocheva
Health Science Community Will Miss This Bright and Uniting Star: In Memory of Professor Gjumrakch Aliev, M.D, Ph.D. Cancers 13 (8) (2021)
Alena Shalimova, Viktoria Babasieva, Vladimir N Chubarev, Vadim V Tarasov, Helgi Birgir Schiöth, Jessica Mwinyi
Therapy response prediction in major depressive disorder: current and novel genomic markers influencing pharmacokinetics and pharmacodynamics. Pharmacogenomics 22 (8) (2021)